Andrew Kaplan is a first-chair trial attorney who has led multiple jury and bench trials both in private practice and while serving in the Civil Division, Torts Branch, of the U.S. Department of Justice. He frequently represents clients as national, as well as international, coordinating counsel in mass tort litigation, including mass actions, class actions, and multidistrict litigation. Andrew currently represents clients in two of the largest pharmaceutical MDLs in the United States and is national counsel for two medical device manufacturers in their multistate dockets of product liability litigation. In this centralized role, Andrew helps clients develop and implement their litigation strategy while minimizing risk and maximizing consistency and efficiency, including identifying specific areas of need, such as regulatory compliance, government reporting, or public disclosures, and building a team with tailored experience. From a global perspective, these include anticipating the impacts of litigation and regulatory actions in individual countries on a company’s broader strategy.

Informed by his litigation experience, Andrew also counsels clients on risk mitigation and compliance programs. His practice focuses on product risk management issues and responding to related government civil enforcement actions. Through proactive risk management, Andrew has helped his clients avoid or lessen the impact of litigation.

Andrew is ranked by Chambers USA for Product Liability & Mass Torts-USA-Nationwide ranking. Chambers USA notes that Andrew is held in high regard for the caliber of his advocacy in product liability litigation. He also serves as co-chair of the firm’s Litigation Group.

Andrew maintains an active pro bono practice focused on representing victims of domestic violence in obtaining and enforcing civil protection orders.